# CNS Study of Patients Switching From Tacrolimus to Envarsus

> **NCT03270462** · PHASE4 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 20 (actual)

## Conditions studied

- Renal Transplant Patients

## Interventions

- **DRUG:** Envarsus XR

## Key facts

- **NCT ID:** NCT03270462
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2020-05-02
- **Final completion:** 2020-06-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03270462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03270462, "CNS Study of Patients Switching From Tacrolimus to Envarsus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03270462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*